MEZZETTI, Andrea
 Distribuzione geografica
Continente #
NA - Nord America 12.351
EU - Europa 9.842
AS - Asia 8.546
SA - Sud America 949
AF - Africa 106
Continente sconosciuto - Info sul continente non disponibili 18
OC - Oceania 9
Totale 31.821
Nazione #
US - Stati Uniti d'America 12.106
SG - Singapore 3.159
CN - Cina 2.807
UA - Ucraina 1.769
IE - Irlanda 1.422
IT - Italia 1.393
TR - Turchia 1.345
GB - Regno Unito 1.219
SE - Svezia 1.164
DE - Germania 934
FR - Francia 897
BR - Brasile 805
IN - India 512
FI - Finlandia 476
VN - Vietnam 370
RU - Federazione Russa 276
CA - Canada 145
MX - Messico 76
PL - Polonia 76
AR - Argentina 61
BD - Bangladesh 50
JP - Giappone 50
ES - Italia 48
ZA - Sudafrica 45
KR - Corea 35
NL - Olanda 32
HK - Hong Kong 31
IQ - Iraq 31
BE - Belgio 29
CZ - Repubblica Ceca 28
IL - Israele 25
EC - Ecuador 24
PK - Pakistan 22
ID - Indonesia 21
IR - Iran 19
LT - Lituania 17
AT - Austria 16
EU - Europa 16
MA - Marocco 14
CO - Colombia 13
EG - Egitto 12
KE - Kenya 12
PY - Paraguay 11
UZ - Uzbekistan 11
VE - Venezuela 11
UY - Uruguay 9
GR - Grecia 8
RO - Romania 8
AE - Emirati Arabi Uniti 7
JO - Giordania 7
MY - Malesia 7
SA - Arabia Saudita 7
TN - Tunisia 7
CL - Cile 6
DZ - Algeria 6
HN - Honduras 5
PE - Perù 5
AU - Australia 4
AZ - Azerbaigian 4
CR - Costa Rica 4
NO - Norvegia 4
NP - Nepal 4
NZ - Nuova Zelanda 4
TW - Taiwan 4
AL - Albania 3
CH - Svizzera 3
CI - Costa d'Avorio 3
DK - Danimarca 3
GT - Guatemala 3
KZ - Kazakistan 3
MD - Moldavia 3
RS - Serbia 3
TT - Trinidad e Tobago 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AO - Angola 2
BG - Bulgaria 2
BH - Bahrain 2
BO - Bolivia 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
GE - Georgia 2
HU - Ungheria 2
PS - Palestinian Territory 2
SN - Senegal 2
SR - Suriname 2
BB - Barbados 1
BN - Brunei Darussalam 1
BS - Bahamas 1
DM - Dominica 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GD - Grenada 1
KG - Kirghizistan 1
KI - Kiribati 1
KW - Kuwait 1
LV - Lettonia 1
MC - Monaco 1
MN - Mongolia 1
MU - Mauritius 1
Totale 31.811
Città #
Singapore 2.293
Jacksonville 1.945
Chandler 1.722
Dublin 1.408
Southend 886
Izmir 728
Ashburn 678
Princeton 675
Beijing 640
Dallas 537
Nanjing 533
Dearborn 406
Wilmington 381
Los Angeles 368
Munich 345
Cambridge 323
The Dalles 323
New York 275
Tongling 258
Santa Clara 226
Nanchang 214
Ann Arbor 184
Buffalo 167
Chieti 152
Altamura 151
Woodbridge 148
Ho Chi Minh City 141
Helsinki 118
Shenyang 116
Boardman 113
Hebei 99
São Paulo 96
Houston 88
Tianjin 88
Jiaxing 72
Council Bluffs 71
Washington 71
Milan 70
Hanoi 68
Grevenbroich 66
Montreal 65
Warsaw 62
Brooklyn 56
Denver 55
Kunming 55
Rome 52
Changsha 51
Hefei 50
Jinan 47
Pescara 45
Stockholm 45
Tokyo 44
Chennai 43
Hangzhou 43
Toronto 43
Redondo Beach 42
Moscow 41
Rio de Janeiro 40
Johannesburg 38
Norwalk 38
San Mateo 38
London 36
Orange 35
Poplar 34
Seattle 34
Seoul 33
Orem 32
Chicago 31
Hong Kong 31
Auburn Hills 30
Phoenix 30
Mexico City 29
Atlanta 28
Augusta 28
Zhengzhou 28
Brussels 27
Ningbo 27
Guangzhou 26
San Jose 26
Boston 25
Brno 24
Lanzhou 24
Manchester 24
Turku 24
Da Nang 23
Changchun 22
Taizhou 19
Curitiba 17
Falls Church 17
Frankfurt am Main 17
Haiphong 17
Leawood 17
San Francisco 17
Querétaro 16
Belo Horizonte 15
Tappahannock 15
Ankara 14
Kocaeli 14
Ninh Bình 14
Nuremberg 14
Totale 19.170
Nome #
Indici di rigidità arteriosa e rischio cardiovascolare globale: risultati da una popolazione abruzzese in prevenzione primaria 520
Rimodellamento concentrico del ventricolo sx in pazienti con ipertensione essenziale: è un pattern geometrico omogeneo? 247
Rosuvastatin reduces Matrix Metalloproteinase (MMP)-9 and Plasminogen Activator Inhibitor (PAI)-1 expression via a microRNA-dependent pathway 231
MicroRNA profiling in migraine without aura: Pilot study 228
Ouabaina endogena, pattern emodinamico e geometria ventricolare sx nell'ipertensione essenziale. 198
A unique microRNA signature associated with plaque instability in humans. 173
Vitamin E supplementation normalizes LDL susceptibility to oxidation in well controlled uncomplicated type II diabetes mellitus 167
(Dis)-agreement among Cardiovascular Risk Calculators in clinical practice 159
A prothrombotic state 155
Suppression of RAGE as a basis of simvastatin-dependent plaque stabilization in type 2 diabetes. 153
Increased expression of transforming growth factor-beta1 as a stabilizing factor in human atherosclerotic plaques. 151
Bioequivalence study of two tablet formulations of ramipril in healthy volunteers 148
Bioequivalence study of two capsule formulations of omeprazole in healthy volunteers 146
Blood cardioplegia: could it protect the ischemic-reperfused human myocardium through antioxidant-type mechanisms? 145
Il trattamento con Metformina riduce i livelli di alcuni indicatori di stress ossidativi in diabetici di tipo 2 144
Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteases activity 141
Differences in blood pressure according to body position (supine, Fowler’s and sitting) in hypertensive subjects 141
Multicentric cohort study on the long-term efficacy and safety of electronic cigarettes: Study design and methodology 141
Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty. 140
OVEREXPRESSION OF TOLL LIKE RECEPTOR 4 AS A BASIS OF CYCLOOXYGENASE 2-DEPENDENT ATHEROSCLEROTIC PLAQUE INSTABILITY IN HUMANS. 139
Necrotizing fasciitis caused by Pseudomonas Aeruginosa 138
'White-coat' hypertension in patients with newly diagnosed hypertension: evaluation of prevalence by ambulatory monitoring and impact on cost of health care 136
White-coat resistant hypertension 136
EGFR mutations in non-small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment. 135
Plasma exosome microRNA profiling unravels a new potential modulator of adiponectin pathway in diabetes: effect of glycemic control 135
A unique microRNA signature associated with ischemic stroke in humans 134
Overexpression of microRNA-145 in atherosclerotic plaques from hypertensive patients 133
Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty. 132
Additional Antihypertensive effect of fluvastatin in hypertensive and hypercholesterolemic patients treated with trandolapril. 130
A 31P-Nuclear magnetic resonance study of intermittent warm blood cardioplegia 130
A Polymorphism in the Cyclooxygenase 2 Gene as an Inherited Protective Factor Against Myocardial Infarction and Stroke 130
Contribution of myofascial trigger points to migraine symptoms 130
Low density lipoprotein oxidation and antioxidant vitamins in dipper and nondipper hypertensive patients 129
[Controllo dei fattori di rischio cardiovascolare nella comune pratica clinica in un campione di pazienti in prevenzione secondaria rappresentativo della popolazione abruzzese] 129
Circadian variations in antioxidant defences and lipid peroxidation in the rat heart 128
Sarcoidosis: Old certainties and new perspectives [La sarcoidosi: Vecchie certezze e nuove prospettive] 128
Attività della paraoxonasi sierica in pazienti con ipertensione arteriosa essenziale. 127
Relationship between oxidative stress, monocyte activation and restenosis after coronary angioplasty. 127
Cardiovascular risk in patients receiving double therapy with false and true nonresponder hypertension. 127
Association between prostaglandin E receptor subtype EP4 overexpression and unstable phenotype in atherosclerotic plaques in human. 127
Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus 126
Use of Contrast-enhanced ultrasound (CEUS) in systemic mastocytosis. Report of two cases 126
Ipertensione arteriosa ed algosensibilità muscolare 125
MicroRNA profiling reveals new potential modulators of insulin-resistance and cardiovascular risk in type 2 diabetes 125
ATP-binding cassette transporter A1 (ABCA1) overexpression in hypercholesterolemic plaques: a potential molecular explanation 123
Cephalosporins are scavengers of hypochlorous acid 123
Effect of Rosuvastatin on ABCA1 and ABCG1 expression in human atherosclerotic plaques: results from the QUASAR study 123
Guidelines enforcement and clinical outcome 123
Angiotensin-converting enzyme inhibitors counteract hypoxia-induced coronary constriction in the isolated rat heart 122
Effect of Rosuvastatin on MicroRNAs expression in human atherosclerotic plaques: results from Quasar Study 122
Blunted nocturnal fall in blood pressure and oxidative stress in men and women with essential hypertension. 121
New insights into the cardiovascular risk of migraine and the role of white matter hyperintensities: is gold all that glitters? 121
Transmural distribution of antioxidant defences and lipid peroxidation in the rabbit left ventricular myocardium 120
Efficacy of a nurse-led email reminder program for cardiovascular prevention risk reduction in hypertensive patients: a randomized controlled trial. 120
Cigarette smoke, ferritin, and lipid peroxidation 120
Effects of vitamin E supplementation on intracellular antioxidant enzyme production in adolescents with type 1 diabetes and early microangiopathy. 119
Heightened free radical activity in angina pectoris 119
ABCA-1 expression is reduced in atherosclerotic plaques from hypertensive patients: a new potential link between hypertension and atherosclerosis 119
High preprocedural non-HDL cholesterol is associated with enhanced oxidative stress and monocyte activation after coronary angioplasty: possible implications in restenosis. 118
The black esophagus 118
Association between 5-lipoxygenase expression and plaque instability in humans. 118
Vitamin E inhibits enhanced F2 isoprostane biosynthesis in type IIA hypercholesterolemia 116
Novel determinants of plaque instability. 116
Mutational analysis of the HER2 gene in lung tumors from Caucasian patients: mutations are mainly present in adenocarcinomas with bronchioloalveolar features. 116
LDL-Apheresis abruzzo network: an old-new opportunity for the management of patients at high cardiovascular risk. 116
Int6 expression can predict survival in early-stage non-small cell lung cancer patients. 116
Low density lipoprotein oxidation in white coat and sustained hypertension (pubbl. su Am J Hypertension). 115
Ossidazione delle LDL e vitamine antiossidanti in pazienti ipertesi dipper e nondipper. 115
Aortic glutathione-related antioxidant defences in rabbits subjected to suprarenal aortic coarctation hypertension 115
La Sindrome Miofasciale come fattore di attivazione della sintomatologia dolorosa della Fibromialgia 115
Blood cardioplegia reduces oxidant burden in the ischemic and reperfused human myocardium 115
Vascular characteristic in hypertensive patients with different left ventricular morphology 114
Effects of irbesartan on intracellular antioxidant enzyme expression and activity in adolescents and young adults with early diabetic angiopathy 114
La gestione del profilo lipidico nei pazienti in prevenzione secondaria sul territorio: lo studio ELL 114
Effect of 2-year treatment with low-dose rosuvastatin on intima-media thickness in hypercholesterolemic subjects with asymptomatic carotid artery disease 114
Blood pressure variability and cardiovascular risk in treated hypertensive patients. 114
Paraoxonase activity is significantly reduced in smokers. Effect of vitamin E supplementation 113
Overexpression of ABCA1 in human plaques exposed to hypercholesterolemia: the role of microRNA modulation 113
Cardiovascular outcome in treated hypertensive patients with responder, masked, false resistant, and true resistant hypertension. 113
Effect of ischemia and reperfusion on antioxidant enzymes and mitochondrial inner membrane proteins in perfused rat heart. 112
[Physiopathological bases of the medical treatment of portal hypertension]. 112
Antioxidant metabolic mechanisms in hypertensive and atherosclerotic arterial wall 112
The (K+)ey of the problem 112
Heparin: does it act as an antioxidant in vivo? 111
Aortic antioxidant defence mechanisms during the progression of atherosclerosis in cholesterol-fed rabbits 111
Impaired left ventricular relaxation and vasodilatory reserve in type I microproteinuric diabetics. 111
Lower rate of cardiovascular complications in patients on bolus insulin analogues: a retrospective population-based cohort study 111
Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E(2)-dependent plaque instability. 110
Distribuzione transmurale dei sistemi antiossidanti e della perossidazione lipidica nel ventricolo sinistro di coniglio 110
Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: effects of statin therapy. 109
Cardiovascular and renal events in uncomplicated mild hypertensive patients with sustained and white coat hypertension 109
Antiproliferative effect of deferoxamine on vascular muscle cells in vitro and in vivo. 109
Viscero-visceral hyperalgesia: characterization in different clinical models 109
Effect of ischaemia-reperfusion on glutathione peroxidase, glutathione reductase and glutathione transferase activities in human heart protected by hypothermic cardioplegia. 109
Tricuspid valve endocarditis complicated by septic pulmonary embolism in an intravenous drug user 109
ABCA-1 Expression is reduced in atherosclerotic plaques of hypertensive patient: a new link between hypertension and atherosclerosis 109
Ambulatory blood pressure stage 108
The role of nitric oxide in the development of diabetic angiopathy. 108
Relationship between reduced BCL-2 expression in circulating mononuclear cells and early nephropathy in type 1 diabetes. 108
Ensuring Longer Life Study. A new model for an integrated management of patients at high cardiovascular risk. 108
Totale 13.210
Categoria #
all - tutte 123.200
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 123.200


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.143 0 0 0 0 0 425 28 16 206 315 66 87
2021/20221.420 33 27 14 304 145 19 23 101 113 41 175 425
2022/20234.677 357 617 246 541 433 977 292 325 605 63 123 98
2023/20242.193 169 74 153 64 117 698 514 60 25 71 15 233
2024/20255.404 320 851 709 72 154 215 196 253 542 239 698 1.155
2025/20265.615 1.017 417 1.028 1.475 1.125 553 0 0 0 0 0 0
Totale 32.272